Eli Lilly and Company · 1 day ago
Director - Heart Failure Research
Indianapolis, IN
Full-time
Onsite
Lead/Staff, Director/Executive
$148K/yr - $257K/yr
5+ years expEli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana, focused on discovering and developing life-changing medicines. The Director of Heart Failure Research will provide strategic vision and leadership for heart failure drug discovery and development programs, while managing a team of scientists and collaborating across various functions to drive program strategies.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Provide strategic vision and direction for heart failure drug discovery and development programs, from target identification through IND-enabling studies
Lead and advise on the design, execution, and interpretation of in vivo and in vitro pharmacology studies to assess the efficacy, pharmacokinetics (PK), pharmacodynamics (PD), and safety of therapeutic candidates with the team
Identify robust animal models of heart failure (including HFpEF and HFrEF) and other cardiovascular diseases using internal and external resources
Serve as a subject matter expert on heart failure biology, pathology, current treatments and next generation approaches to therapeutics
Stay current with scientific literature, technology advancements, and external competitor progress to ensure the company's research remains innovative and competitive
Lead, mentor, and manage a team of junior and senior scientists, fostering a collaborative, high-performing, and innovative culture
Manage strategies, priorities, timelines and resource allocation to ensure program achievements are met efficiently
Develop comprehensive project plans and risk mitigation strategies to address scientific and operational challenges
Communicate program progress, risks, and results to senior management and cross-functional partners
Enable outsourcing activities with contract research organizations (CROs) for specialized studies, ensuring quality and prompt execution
Collaborate with cross-functional teams, including medicinal chemistry/genetic medicines/bioproducts, toxicology/ADME, bioinformatics, and regulatory affairs, to integrate data and drive program strategies
Represent the preclinical team in external meetings with scientific experts, key opinion leaders, and potential partners
Contribute pharmacology data to regulatory filings, including Investigational New Drug (IND) submissions
Support business development efforts by evaluating external opportunities for potential in-licensing
Qualification
Required
Ph.D. in cardiovascular biology, pharmacology, molecular biology, or a related field
5+ years of industry experience in preclinical drug discovery and development, with a proven track record of advancing therapeutic programs
Strong expertise in heart failure, including a deep understanding of its pathophysiology, preclinical models, and current therapeutic landscape
Preferred
Demonstrated leadership and people-management skills, with experience mentoring and developing scientific talent
Ability to make data-driven decisions and find innovative solutions to overcome scientific and operational obstacles
Strong project management skills, including the ability to manage complex research programs with multiple workstreams
Excellent written and verbal communication skills, with the ability to present complex scientific data to diverse audiences
Strong interpersonal skills for effective collaboration with internal teams, external partners, and vendors
Benefits
Company-sponsored 401(k)
Pension
Vacation benefits
Eligibility for medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
10001+ employees
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
David Ricks
Chair, CEO
Lucas Montarce
Executive Vice President and Chief Financial Officer
Recent News
2026-01-06
2026-01-06
Company data provided by crunchbase